>>There could be more selling ahead depending on how far along they are in liquidating the fund.
Good point. Be interesting to look at their biotech holdings as a percentage of the float of each stock - if they are all moving in unison, then once they stop going down that will be the buying opportunity.
So if someone were inclined, I'd suggest make a "Visium biotech index" weighted by float proportion. Graph that index relative to some broader biotech index, and just buy like hell once it turns positive.
Market Data 
Markets 
AI
